iRhythm Technologies (NASDAQ:IRTC – Free Report) had its target price reduced by Evercore ISI from $185.00 to $175.00 in a report released on Tuesday,Benzinga reports. They currently have an in-line rating on the stock. Several other equities analysts have also recently issued reports on IRTC. Wells Fargo & Company lifted their price objective on iRhythm […]

Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) had its price objective raised by Needham & Company LLC from $70.00 to $78.00 in a report issued on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s price target would suggest a potential upside of 11.00% from the company’s previous […]